Stocks and Investing Stocks and Investing
Tue, January 18, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (BIIB) at Buy with Decreased Target to $360 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Chris Cooley Downgraded (ALC) to Hold and Decreased Target to $86 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mitch Kummetz Initiated (UAA) at Hold on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Simeon Siegel Upgraded (UAA) to Buy and Increased Target to $25 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Sheila Kahyaoglu Maintained (TXT) at Strong Buy and Held Target at $90 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mitch Kummetz Initiated (WWW) at Hold on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
George Choi Maintained (WYNN) at Hold with Increased Target to $95 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Deane Dray Maintained (XYL) at Buy and Held Target at $134 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Anthony Paolone Maintained (UDR) at Buy with Increased Target to $63 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Anthony Powell Maintained (UDR) at Buy and Held Target at $63 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Kevin Fischbeck Maintained (UNH) at Strong Buy and Held Target at $574 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Clarke Jeffries Initiated (VTEX) at Buy and Held Target at $13 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Diego Aragao Upgraded (VTEX) to Strong Buy and Decreased Target to $16 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mitch Kummetz Initiated (VFC) at Hold on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Tyler Broda Upgraded (VALE) to Hold and Increased Target to $17 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Raghuram Selvaraju Maintained (URGN) at Strong Buy with Decreased Target to $34 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mircea Dobre Maintained (URI) at Hold and Held Target at $317 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jason Deleeuw Maintained (V) at Buy and Held Target at $275 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Steven Zaccone Maintained (WSM) at Hold with Decreased Target to $83 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Begleiter Upgraded (WLK) to Strong Buy and Increased Target to $125 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Robert Koort Maintained (WLK) at Hold with Increased Target to $129 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Long Maintained (WFC) at Buy with Increased Target to $65 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Stephen Biggar Maintained (WFC) at Strong Buy with Increased Target to $65 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Pancari Maintained (WFC) at Buy with Increased Target to $65 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Chase Mulvehill Maintained (WMB) at Strong Buy with Increased Target to $35 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Ng Initiated (SOFI) at Hold and Held Target at $16 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Kamil Mielczarek Upgraded (SNOW) to Buy on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Todd Fowler Maintained (SNDR) at Buy with Increased Target to $32 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Friedman Reiterated (STNE) at Buy and Held Target at $35 on, Jan 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (SRPT) at Hold with Increased Target to $92 on, Jan 18th, 2022

Matthew Harrison Maintained (SRPT) at Hold with Increased Target to $92 on, Jan 18th, 2022


Published on 2024-10-27 19:17:44 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Hold with Increased Target from $90 to $92 on, Jan 18th, 2022.

Matthew has made no other calls on SRPT in the last 4 months.



There are 7 other peers that have a rating on SRPT. Out of the 7 peers that are also analyzing SRPT, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Judah Frommer of "Credit Suisse" Maintained at Hold with Decreased Target to $95 on, Friday, October 15th, 2021


These are the ratings of the 6 analyists that currently disagree with Matthew

  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy and Held Target at $122 on, Thursday, January 13th, 2022
  • Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $150 on, Wednesday, January 5th, 2022
  • Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $125 on, Thursday, December 9th, 2021
  • Anupam Rama of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $130 on, Friday, November 5th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $145 on, Thursday, November 4th, 2021
  • Yun Zhong of "BTIG" Maintained at Strong Buy with Increased Target to $125 on, Tuesday, October 12th, 2021

Contributing Sources